title: Letter: Safety and Efficacy Issues of Tirofiban Use in Endovascular Procedures: What Are the Actual Indications?
authors.affiliation: *Neurosurgery Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy ‡PhD Program in Experimental Medicine, Università degli Studi di Pavia, Pavia, Italy §Platelets Physiopathology Laboratory, Department of Internal Medicine ¶Interventional Neuroradiology Unit, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
authors.forename: Daniele
authors.initials: D
authors.lastname: Bongetta
authors.forename: Cesare
authors.initials: C
authors.lastname: Zoia
authors.forename: Federica
authors.initials: F
authors.lastname: Melazzini
authors.forename: Elvis
authors.initials: E
authors.lastname: Lafe
authors.forename: Federico
authors.initials: F
authors.lastname: Zappoli Thyrion
authors.forename: Paolo
authors.initials: P
authors.lastname: Gaetani
mesh_terms: D057510:Endovascular Procedures; D006801:Humans; D009203:Myocardial Infarction; D010975:Platelet Aggregation Inhibitors; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives
chemical_list: D010975:Platelet Aggregation Inhibitors; D014443:Tyrosine; D000077466:Tirofiban